NCT01941654View on ClinicalTrials.gov

ATOM_local Ablative Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 18, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

May 28, 2020

Conditions
NSCLCActivating EGFR Mutation
Interventions
RADIATION

preemptive local ablative therapy

DRUG

Oral TKI

Trial Locations (1)

Unknown

Department of Clinical Oncology, Hong Kong

All Listed Sponsors
collaborator

Pamela Youde Nethersole Eastern Hospital

OTHER

lead

Chinese University of Hong Kong

OTHER

NCT01941654 - ATOM_local Ablative Therapy | Biotech Hunter | Biotech Hunter